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Microtus sp. have been used in microcosm simulations of polluted 
environments. In this study, female Microtus montanus (mountain vole), 
8 - 12 weeks of age, were pretreated with phenobarbital (PB), B-naphtho-
flavone (BNF), or Aroclor 1254 (PCB) for 3 consecutive days. Doses 
ranged from 5 to 80 mg/kg for each pretreatment, while control animals 
received saline or corn oil only. The voles were sacrificed 1 day after 
the last dose of PB and 2 days after BNF and PCB. Hepatic microsomal 
enzyme activity of aniline hydroxylase (AH), p-nitroanisole-0-demethyl-
ase (PNA) and cytochrome C reductase (CCR) were measured in relation to 
dose and type of inducer pretreatment. PB produced an induction for 
all 3 enzyme systems at the higher doses. Variation of PB dose from 5 
to 80 mg/kg produced a biphasic effect in AH, PNA increased with each 
higher dose, and CCR showed a triphasic effect. BNF caused no signifi-
cant change in AH activity, a biphasic response in PNA, and a triphasic 
effect in CCR with the highest activity at the 20 mg / kg dose. PCB dem-
ix 
onstrated slight induction at low doses but higher doses produced no 
change or a decrease in enzyme activity. No increase in SGPT levels or 
serum malathion carboxylesterase occurred. Histological investigations 
revealed 2 morphological phases related to the type of induction. Low 
level induction showed foamy, vacuolated hepatocytes, while high induc-
tion produced very large, hypertrophied hepatocytes. A positive con-
trol for hepatic necrosis using 0.1 ml/kg carbon tetrachloride showed 
significant increases in serum enzymes and severe centrilobular and mid-
zonal acute hepatic necrosis. Therefore, these results show a differ-
ence in induction potential of BNF and PCB compared to other rodents. 
Also, this study indicates the importance of inducer dose on the effect 
of hepatic monooxygenase activity. 
( 91 pages) 
INTRODUCTION 
The hepatic monooxygenase system plays an important role in both 
the detoxification as well as in the activation of numerous xenobiotics. 
A considerable amount of work has been done on the inductive properties 
of liver monooxygenases in laboratory inbred animals. Little attention 
has been shown toward outbred or wild animals. Nebert and Gelboin 
(1969), Walker (1978), and Kato (1979) all illustrate the high diversity 
of species differences in hepatic monooxygenases activity and stress the 
importance of studying various species of animals. 
Investigations on monooxygenase activity were performed in endrin-
resistant and susceptible pine voles, Microtus pinetorum(Hartgrove et 
al., 1977) and in the grey-tailed vole, !:1_. canicandus (Brindley, 1979), 
but little work has been published on the mountain vole,!:!_. montanus. 
Results of Makary and Brindley (1983) show the patterns of microsomal 
induction of bi phenyl hydroxylation of!:!_. montanus to be much different 
than reported for rats or mice. The pattern resembles the induction 
seen in hamsters. Wang (1981) studied the inducing effects of pheno-
barbital (PB), 3-methylcholanthrene (3-MC), and B-naphthoflavone (BNF) 
on 2 strains of mice, B6 and 02, The B6 mice showed microsomal en-
zyme induction to all 3 pretreatments, whereas the special strain of 
D2 mice were induced by PB but not by 3MC or BNF. Preliminary tests 
showed !:1_. montanus to have hepatic microsomal enzyme induction similar 
to that of the 02 strain of mice. 
Voles have been used in microcosms for environmental chemical ex-
posure studies (Cole et al., 1976, and Gile and Gillett, 1977). The 
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Environmental Protection Agency has also used Microtus sp. in microcosm 
exposure studies and found these animals useful in modeling environ-
mental accumulation of pollutants. More knowledge can be obtained 
from microcosm studies by a better understanding of the toxicology 
and physiology of the vole. 
Chemicals often used by hepatic induction are PB for "cytochrome 
P-450type" induction and BNF for a "cytochrome P-448 type 11 induction. 
Arocl or 1254 (PCB) shows both 11 types 11 of inducing properties as reported 
by Alvares and Kappas (1977) and Ryan et al. (1979) . These 3 enzyme 
inducers develop a good insight to the inductive responses of hepatic 
monooxygenases. Studies incorporating the use of PB, BNF, and/or PCB 
for enzyme induction investigation usually use only one or two differ-
ent dose levels. Little is known about the effects of varying the 
inducer pretreatment levels on the hepatic monooxygenase activity. 
It is not known if, at higher dos es, these inducers become increasingly 
more toxic, resulting in a decrease in the inductive propert i es. 
Assessment of liver damage is often determined by levels of 1 iver 
enzymes in the serum. Compared to other liver function tests, levels 
of serum glutamic pyruvic transaminase (SGPT) appears to be a more 
sensitive test in determining liver damage (Plaa, 1976). Talcott and 
Ketterman (1981) have shown that serum levels of malathion carboxyl-
esterase may fluctuate due to structural changes in liver endoplasmic 
reticulum. Monitoring serum enzyme levels as an indication of bio~ 
chemical changes in the liver during enzyme induction has not been 
fully investigated. 
The purpose of this study was based on four main objectives. The 
first was to further understand the hepatic monooxygenase system and 
its induction potentials of Microtus montanus using the inducers PB, 
BNF and Aroclor 1254. Second, to compare the relation of dose and type 
of inducer pretreatment to the level of microsomal enzyme activity. 
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The third objective was to quantify any change in SGPT and serum mala-
thion carboxylesterase due to the dose and type of inducer administered 
to M. montanus . The last objective was to determine any histological 
changes in the liver of the voles based on the dose and type of inducer. 
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LITERATURE REVIEW 
Cytochrome P-450 Dependent Monooxygenase System 
The cytochrome P-450 dependent monooxygenase system plays an im-
portant role in both the detoxification as well as the activation of 
numerous xenobiotics. This enzyme system is found in bacteria, yeasts, 
fish, birds, mammals and other life forms. In mammalian systems, the 
monooxygenases are incorporated in many tissues with the highest activ-
ity occurring in hepatic tissue. 
Hepatic monooxygenases deto xify some xenobiotics by an hydro xyla-
tion of lipophilic compounds, allowing easier excretion of the metabo-
lites. Toxic compounds may be converted, by the hepatic oxidative 
reaction, to a less potent metabolite resulting in a decrease in to xic-
ity. Lampe and Butschak (7978) discussed the role of cytochrome P-450 
in the activation of several xenobiotics. This enzyme system may 
cause the formation of reactive epoxides or hydroxylated products which 
may eventually transform into electrophilic reactants. These react-
ants can then produce cytotoxic, mutagenic, teratogenic or carcinogenic 
effects depending on the dose and other pharmacokinetic parameters 
involved. 
Sato and Omura (7978), in their book, have presented the history 
and current understanding of cytochrome P-450. Recent reviews by 
Walker (7978), Bresnick (7978), Kato (7979), Nebert (7979), Ullrich 
(7979), Rees (7979), and Goldberg (7980), have looked at the induction 
capabilities of the cytochrome P-450 monooxygenase system and the 
occurrence of species differences. 
Mechanism and organization of the hepatic 
monooxygenase system 
The hepatic monooxygenase system is located in the endoplasmic 
reticulum of hepatocytes. These systems are isolated in vitro in 
vesicles of endoplasmic reticulum called microsomes prepared by cen-
trifuging the mitochondrial supernatant 105,000 x g for 1 hr (Gold-
stein et al., 1974). The resultant pellet, the microsomal fraction, 
contains hemoproteins incorporated within the membrane vesicles. 
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These hemoproteins are known as cytochrome P-450. The name comes from 
the absorption peak seen at 450 nm when the complex of the reduced form 
of the hemoprotein is bound to carbon monoxide (Sato and Omura, 1978). 
The monooxygenase system utilizes electron transfer complexes to 
permit the hydroxylation of various substrates. The substrate binds 
with the oxidized form of cytochrome P-450 and is reduced by accepting 
one electron from a flavoprotein called NADPH cytochrome P-450 reduct-
ase (Yang, 1977; Sato and Omura, 1978}, Figure l. Molecular oxygen 
is then bound to the reduced P-450-substrate complex. A second electron 
is received by the complex forming an 11 acti vated oxygen" allowing one 
oxygen atom to be inserted into the substrate. This second electron 
can be supplied by either NADPH (by way of the flavoprotein) or NADH 
using the transport systems of a flavoprotein and cytochrome b5 (Hilde-
brant and Estabrook, 1971). The other oxygen atom forms water, and the 
oxidized substrate is released allowing the cytochrome P-450 to return 
to the oxidized form. The electron transfer system is shown in Figure 
1. 
The organization of the monooxygenase enzymes within the membrane 
have been reviewed by Yang (1977). Franklin and Estabrook (1971) re-
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NADPH-cytochrome P-450 reductase as being surrounded by many cytochrome 
P-450 molecules forming fixed clusters throughout the membrane. Ac-
cording to the rigid system, when 50% of the reductase is inactivated, 
only 50% of the cytochrome P-450 can be enzymatically reduced. Frank-
lin and Estabrook (1971) showed this to occur using mersalyl to inacti-
vate the reductase. 
The "nonrigid" model was adopted by Yang (1977) showing that cyto-
chrome P-450 and the reductase are not rigidly associated and that these 
enzymes are free to move laterally in the membrane. This was illustrat-
ed by inactivating up to 80% of the NADPH-cytochrome reductase with 
mersalyl, yet, most all of the cytochrome P-450 was still reduced enzy-
matically, but at a slow rate. 
The model described by Peterson et al. (1976), incorporates both 
the "rigid" and "nonrigid" models by looking at the temperature depen-
dent kinetics of cytochrome P-450 reductase. This model has the reduc-
tase, surrounded by several cytochrome P-450 molecules, partially pro-
truding out of the membrane. Also, a number of cytochrome P-450 mole-
cules are freely dispersed in the membrane and all the enzymes have free 
lateral movement within the membrane. It is reasonable to state that 
the distribution of enzymes, in the microsomal membrane, is hetero-
genous and that they are mobile within the membrane. There tends to 
be more support for the model adopted by Peterson et al. (1976) in 
describing the organization of the microsoma1 monooxygenase system. 
Induction capabilities and multiple 
forms of cytochrome P-450 
The term hepatic enzyme induction refers to the ability of a sub-
strate to enhance the activity of that enzyme, and usually related en-
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zymes, by promoting the synthesis of the enyzmes. Kupfer (1970) looked 
at the variation in hexabarbital-induced sleep in rats. Rats pretreated 
with phenobarbital or DDT had a considerable decrease in their 
hexabarbital-induced sleep compared to controls. This is due to tht 
induction capabilities of the pretreatment compounds on the hexabar-
bital metabolizing enzyme causing hexabarbital to become inactivated 
and excreted more rapidly. 
The preferred procedure to find the degree of induction of 
hepatic enzymes is to prepare hepatic microsomal fractions and assay 
the enzyme activity with suitable substrates (Conney, 1967). Quite 
often an aromatic hydroxylation, i.e. aniline hydroxylase and some 
type of dealkylation, i.e • .E_-nitroanisole-Q_-demethylase, are both in-
vestigated to determine any variations that may occur in the enzyme 
activity dependent on the substrate. Recent studies by Katoh et al. 
(1981) and Rikans and Notley (1982) utilize aniline and p-nitroanisole 
as the substrates to monitor microsomal monooxygenase activity. Cyto-
chrome C reductase activities are often measured to determine the change 
in rate of electron flow to the cytochrome P-450-substrate complex, 
giving an indication of induction. 
Many factors can affect the promotion of enzyme induction. Gold-
berg (1980) mentions some of these important factors as: species var-
iability, induction dependency upon age as well as sex of the animal 
and stage of sexual maturity. Also, seasonal and nutritional factors 
can have an effect on enzyme activity. These fluctuations in activity 
must be considered in studies involving enzyme induction. 
Reviews by Bresnick (1978) and Rees (1979) detailed the mechanism 
of induction at the molecular level. The inducer causes stimulation of 
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nuclear RNA as well as a decrease rate of degradation of mRNA. This 
implies the inducers produce nuclear changes in the cells affecting in-
creased synthesis of the needed enzymes and also decrease the rate of 
degradation of these enzymes. An inducer compound-receptor complex, 
needed to start the chain of actions has not been isolated but believed 
to exist (Rees, 1979; Nebert, 1979) . 
In the review by Nebert and Jensen (1979), a gene locus-Ah, asso-
ciated with AHH activity, also regulates the metabolism of several other 
compounds. Aniline hydroxylase and cytochrome C reductase are not as-
sociated with the Ah locus. As a result, genetic control over enzyme 
metabolism, due to inducers, is specific for some substrates and fairly 
non-specific for many other substrates. Conney (1967) states that there 
are at least two types of inducers; phenobarbital type and 
3-methylcholanthrene type. Many compounds are similar to phenobarbital 
(PB) in stimulating metabolic pathways in liver microsomes including 
oxidation and reduction reactions. Whereas, polycylic aromatic hydro-
carbons, typified by 3-methylcholanthrene (3-MC) and B-naphthoflavone 
(BNF), stimulate a more limited group of enzymes. The PB type inducers 
stimulate a Soret peak of the reduced cytochrome P-450-CO complex around 
450 nm. In contrast, the 3-MC type inducers stimulate a Soret peak of 
the reduced cytochrome-CO complex closer to 448 nm. The differences 
between PB and 3-MC have helped in identification of different forms of 
cytochrome P-450 in the hydroxylation enzyme systems in liver micro-
somes. 
In the review by Nebert (1979), he discusses the possibility of 
mammalian tissues containing hundreds of different inducible forms of 
cytochrome P-450. He compares the diversity of the metabolic capabili-
10 
ties of microsomal monooxygenases to that of the immune system in re-
sponse to antigens. Yet, the actual mechanistic response in both of 
these systems is very specific. Several studies have reported the iso-
lation of different forms of cytochrome P-450. Comai and Gaylor (1973) 
separated three forms of cytochrome P-450 from rat livers. The differ-
ent forms were determined by spectral changes that occur when the P-450 
complexes combined wtih various ligands. Welton and Aust (1974) isolat-
ed these different forms of cytochrome P-450 in rats by 
SDS-polyacrylamide gel electrophoresis. Pretreatment with PB induced 
the P-450 with a molecular weight 44,000, while 3-MC increased the 
amount of P-450 with molecular weight 53,000. The hemoprotein that 
predominated in microsomes of untreated rats had a molecular weight of 
50,000. Haugen et al. (1975) isolated a fourth type of P-450 with 
the molecular weight of 60,000. They also determined the different 
types of cytochrome P-450 hydroxylated various substrates preferential-
ly. 
Recently, considerable work has been done on the inductive effects 
of polychlorinated biphenyls (PCB). Ryan et al. (1977) and Alvares and 
Kappas (1977) both presented results demonstrating that the PCB mixture 
Aroclor 1254 has the inductive potential similar to that of PB and 3-
MC. Yoshimura et al. (1978) investigated the inductive effect of 
Kanechlor 400, a Japanese PCB mixture, and found the similar effect 
seen with Aroclor 1254. Poland and Glover (1977), Parkinson et al. 
(1980) and McKinney and Singh (1981) have studied the structure-activity 
relationship of various PCB congeners on the hepatic monooxygenases. 
The specific congeners produced either; PB type, 3-MC type, both, 
or no effect on the inductive properties. This explains why Aroclor 
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1254, a mixture of various PCB congeners, produces effects similar to 
both PB and 3-MC. Ryan et al. (1979) isolated three specific forms of 
hepatic cytochrome P-450; P-450a, P-450b, and P-450c from rats pretreated 
with Aroclor 1254. The P-450a and P-450b were also found in PB pre-
treated rats but in 3-MC pretreated rats, P-450a and P-450c were pre-
sent. The forms of cytochrome P-450 found in the PB and 3-MC treated 
rats were indistinguishable from the corresponding forms from Aroclor 
1254 treated rats based on spectral changes, enzyme activity and antisera 
testing. 
Species differences in hepatic 
monooxygenase activity 
Detailed reviews by Walker (1978) and Kato (1979) have covered 
differences in hepatic monooxygenase activity of different species. 
Both articles illustrate the wide range of enzyme activity that can 
occur in the monooxygenase system. This variation in detoxifying en-
zymes illustrates the importance in understanding the relative toxicity 
of compounds in different species. 
Philpot and Bend (1975) investigated benzpyrene hydroxylase activ-
ity in 3-MC pretreated rabbit and rat hepatic microsomes. Rabbits 
showed a decrease in benzpyrene hydroxylase when pretreated with 3-MC 
compared to the controls. Rats showed a large induction of benzpyrene 
hydroxylase when pretreated with 3-MC. Similar results are produced 
in study by Miranda and Chhabra (1980). All species tested produced an 
increase in activity of aniline hydroxylase, ethylmorphine demethylase, 
7-ethoxycoumarin deethylase and AHH when pretreated with PB. Pre-
treatment of 3-MC increased ~epatic aniline hydroxylase and AHH activ-
ities in rats, mice, and guinea pigs and 7-ethoxycoumarin deethylase 
activity in mice and rats. In contrast, these enzyme activities were 
inhibited by 3-MC pretreatment in rabbits. 
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Makary and Brindley (1983) investigated species differences in 
biphenyl hydroxylation between the mountain vole and white mice. The 
vole produced increases in 2-, 3-, and 4-hydroxybiphenyl with pretreat-
ment of PB, while the mice only increased in 3- and 4-hydroxybiphenyl. 
With 3-MC or BNF pretreatment, the mice had a high increase in 2-
hydroxylation over 3- and 4-hyrlroxylation; whereas the vole showed 
only slight increases in all 3 metabolites. 
Hepatotoxicity 
The liver is a multifunctional organ, but the main interest of this 
study is the capability of hepatocytes to metabolize xenobiotics. The 
classical way of expressing the relation of the hepatocytes, to the 
vascular supply and the biliary system is by the hexagonal liver lobule 
(Rappaport, 1969). In the center of this lobule is the central vein and 
at each apex of the hexagonal shape is located a portal triad made up 
of the portal vein, hepatic arterial~ and bile duct. Using this con-
figuration, lesions of the liver parenchyma have been described as 
centrilobular, midzonal, or periportal . 
Rappaport (1969) has described the functional unit of the liver as 
the liver acini. This region has the portal triad at the center 
bordered by two or more central veins. The arterial blood as well as 
venous blood from the portal vein passes through the hepatic sinuses in 
close contact with the hepatic cells. 
Hepatocytes lining the sinusoids are thought to have varying de-
gree of enzymatic activity based on the location in the liver lobule. 
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Sweeney et al. (1978a, b) and Wanson et al. (1975) have investigated 
hepatocyte heterogeneity. Wanson, et al. (1975) isolated centrilobulars 
from periportal cells and determined the centrilobular to be larger in 
size and to contain more smooth endoplasmic reticulum. Sweeney et al. 
(1978b) demonstrated that pretreatment with phenobarbital or 
3-methylcholanthrene resulted in different sedimentation velocity pat-
terns. Baron et al. (1978), using immunohistochemical methods, de-
termined that centrilobular hepatocytes contain larger concentrations 
of cytochrome P-450. Baron et al. (1978) also showed that cytochrome 
P-450 induced by 3MC or PB have different distributions in the liver 
lobule. 
The concept of heterogeneity plays an important role in discussing 
liver damage due to chemical exposure. Nakatsugawa et al. (1980) ex-
plains how the liver lobule may function as a "reverse-phase chromato-
graph" during the passage of xenobiotics through the liver. The dif-
ferences of uptake and metabolism of to xic chemicals by hepatocytes 
reflectthemorphological lesion. James et al. (1981) illustrates 
this point well by using 3 different hepatotoxins that produced 3 dif-
ferent necrotic areas within the liver lobule. Allyl alcohol produces 
periportal lesions due to the higher concentrations of alcohol dehy-
drogenase in this region. Alcohol dehydrogenase converts allyl alcohol 
into the toxic compound allyl aldehyde. Bromobenzene and carbon tetra-
chloride are metabolized to toxic products by monooxygenases in the 
centrilobular and midzonal regions. The necrosis produced by bromo-
benzene is predominantly centrilobular whereas carbon tetrachloride-
necrosis is midzonal and centrilobular. This shows how the location of 
the lesion is related to where the compound is metabolically activated. 
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The liver lesion observed due to chemical exposure depends not 
only on the chemical involved, but also the period of exposure. Acute 
exposure usually reveals lipid accumulation in the hepatocytes, cellular 
necrosis, or hepatobilliary dysfunction (Plaa, 1980). Chronic exposures 
result in cirrhosis of the liver or neoplastic changes. 
This study, presented in the following pages, deals with the pos-
sibility of hepatocyte degeneration and necrosis due to acute exposures 
of various chemicals. Degeneration refers to abnormal morphological 
changes which may be seen by c~lular swelling, accumulation of fat with-
in the cell, or the appearance of intracellular inclusions; also there 
may be an abnormal accumulation of extracellular material (Thomson, 
1978). Necrosis refers to rapid tissue death or irreversibl~ degener-
ation. Tissue may be sectioned, fixed and stained to observe any ab-
normal changes produced by an injurious chemical. 
Another procedure to assess liver dysfunctions is to monitor 
serum enzyme levels that vary due to hepatic lesions. Serum glutamic 
pyruvic transaminase (SGPT) activity tends to elevate in animals treated 
with hepatotoxic compounds (Todd-Sanford, 1974). SGPT appears to be 
a more sensitive index of hepatic injury than some of the other serum 
assays (Balazs et al., 1962; Traiger and Plaa, 1971; and Thomson, 
1978). Several recent studies measured SGPT levels to determine the 
degree of hepatotoxicity occuring due to treatments of various chemi-
cals (Freeman and Harbison, 1981; Ueno et al. 1980; and Suarez et al. 
1981). 
Pessayre et al. (1980) looked at SGPT activity and sections of 
livers to determine the extent of hepatotoxicity. They suggested that 
microsomal enzyme inducers may have additive effects on the hepototoxic-
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ity of acetaminophen by increasing the formation of the reactive meta-
bolite. The increases in SGPT levels were well correlated with the 
liver necrosis evident from histological examination. 
High levels of certain serum enzymes may also have a beneficial 
effect in metabolizing toxic compounds to a less reactive form. Studies 
by Seume and O'Brien (1960) and Main and Braid (1962) have shown that 
the low toxicity of malathion in mammals is due to the hydrolysis of 
malathion to the carboxylic acid derivatives by carboxylesterases lo-
cated in the liver and serum. Recent studies have investigated the in-
hibition of serum carbo xylesterase by specific compounds causing an 
i ncrease in malathion toxicity (Mallipudi et al . , 1980 and Umetsu. 
et al., 1981). 
Townsend and Carlson (1981) showed mice pretreated with halogenated 
benzenes responded to malathion treatment with increased levels of 
carboxylesterase activity in the liver and serum. This suggested that 
the increase in serum carboxylesterases may be due to a change occuring 
in the liver. Talcott and Ketterman (1 981) showed that t hese serum 
level s of malathion carboxylesterase may fluctuate due to s tructural 
changes i n t he l iver end op l asm i c ret ic ulum . They showed t hat serum 
malathio n carboxylesterase levels were hig hly correlated with SGOT 
and the highest titer was seen in a perso n overdosed with acetamino-
phen. These results suggested that serum levels of malathion carbox-
ylesterase may increase due to hepatic necrosis, allowing for another 
serum assay to be used in asessing liver dysfunction. 
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Voles 
Voles are small mammals in the Order Rodentia and Family Criceti-
dae. They are abundant and found in most habitat types. Voles are 
considered herbivores, consuming grasses, seeds, and some insects. 
Voles have been used in microcosm exposure studies to evaluate 
the residues of pesticides in model ecosystems. Cole et al. (1976) 
used the prairie vole, Microtus ochrogaster in model ecosystems con-
taining water, soil, growing corn and various invertebrates. The self-
contained environments were exposed to aldrin, DDT, fonofos or meth-
oxychlor. Residues of aldrin and DDT were larger than those of fonofos 
or methoxychlor in the vole. Levels of DOE were greater than DDT in 
the vole, whereas the rest of the ecosystems showed DDT to be higher. 
This indicated that the prairie vole has the ability to metabolize DDT 
to ODE. Further studies on the metabolic capabilities of the vole were 
not conducted. 
Studies by Gile and Gillett (1977) showed residue levels in~-
canicaudus, grey-tailed vole, of some of the insecticides they tested. 
They used microcosm chambers that contained a soil medium, agricultural 
crops, invertebrates and~- canicaudus. 
EPA showed interest in microcosm exposure studies and felt the 
vole was well suited to use in the microcosm chambers (Witt et al. 
1977). This was based on the ease of handling and rearing of the ani-
mals, as well as their behavior seemed suitable for the microcosm 
chamber. The EPA felt a need for more information on the behavior, 
physiology and biochemistry of the vole. 
There has been considerable work done on the pine vole, Pitymys 
pinetorum and its resistance to endrin. Endrin was used in apple or-
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chards for control off. pinetorum for many years and certain popula-
tions developed, where endrin became less effective. Webb and Horsfall 
(1967) reported a resistant strain of pine voles having 12-fold 
greater tolerance than the susceptible strain. They felt it was an ac-
quired resistance caused by many years of endrin exposure. 
Webb et al. (1972) showed the resistant pine vole to have greater 
levels of hepatic benzpyrene hydroxylase activity than the susceptible 
group. They concluded this difference may be genetic as well as an in-
creased inductive potential of endrin. Following this, several studies 
were conducted over the next few years to investigate the resistant 
capabilities of the pine vole. 
In 1973, Hartgrove and Webb studied the activity of hepatic benz-
pyrene hydroxylase in various ages of susceptible and resistant pine 
voles. The resistant voles developed the ability to metabolize benz-
pyrene more rapidly and the levels of hydroxylase activity were always 
higher in the resistant strain. This further indicated a genetic basis 
for endrin resistance. Webb et al. (1973) showed F1 offspring of resis-
tant voles had higher Lo 50 values than susceptible and F1 of a cross 
between resistant and susceptible voles were more susceptible to endrin 
yet still more tolerant than the susceptible F1 offspring. Cross re-
sistance to dieldrin was seen but did not occur with Gophacide, an or-
ganophosphate, or the anticoagulant chlorophacinone. The resistant 
voles LD50 values were lower than the susceptible voles fdr Gophacide 
and chlorophacinore. Webb et al. (1973) believes this is due to in-
crease in metabolic activation of these compounds in the resistant over 
the susceptible strain. 
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Petrella and Webb (1972) and Petrella et al. (1974) showed higher 
excretion rates and an increased metabolism of 14c-endrin in the resis-
tant pine vole, compared to the susceptible vole. Hartgrove et al. 
(1972) reported ethylmorphine ~-demethylase activity was higher in en-
drin resistant voles than the susceptible and that aniline metabolism 
did not show the correlation. 
At the thirteenth annual meetings of the Society of Toxicology, 3 
studies were presented dealing with the pine voles. Hartgrove et al. 
(1974) showed that phenobarbital caused an increase in microsomal ac-
tivity of aniline hydroxylase and ethylmorphine !i-demethylase in both 
strains to an equal degree. The P-450 content also increased in both 
strains. Endrin treatment did not show this inductive effect in either 
strain. Hayes et al. (1974) showed that the binding kinetics of endrin 
was not significantly different in the 2 strains of pine voles. Hund-
ley et al. (1974) reported no difference in endrin concentration in 
pups of dams treated with endrin, between the resistant and susceptible 
voles. Susceptible pups exposed to endrin through the dam's milk showed 
a lower microsomal enzyme activity than the resistant pups. This shows 
that the resistant strain is still less susceptible to endrin at a 
very young age than the susceptible strain. 
The hepatic monooxygenase activity of endrin-resistant and 
-susceptible pine voles were characterized by Hartgrove et al. 
(1977). They used ethylmorphine, aniline and benzo(a)pyrene as sub-
strates and also measured the cytochrome P-450 content. Results of 
the 2 strains were compared against the activity of ICR white mice. 
No significant differences between the 2 strains of voles were seen in 
the control groups although the levels were higher for the 3 substrates 
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in the resistant animals. The endrin treated groups showed varying 
results depending on the substrate used. The ethylmorphine B-demethylase 
and benzpyrene 3-hydroxylation decreased in activity in endrin treated 
voles for both strains. Aniline hydroxylase and benzpyrene V levels max 
showed increasing trends in both strains of voles when endrin was a 
pretreatment. 
The white mice showed different levels of enzyme activity compared 
to the 2 strains of voles. Endrin pretreatment caused an increase in 
ethylmorphine ~-demethylation and aniline hydroxylase activity but a 
decrease in benzpyrene V and 3-hydroxylation. max 
Cytochrome P-450 content was higher in the resistant strain of 
voles. Endrin treatment of the mice and both strains of voles showed 
an increase in cytochrome P-450 content. 
Hartgrove et al. (1977) present some interesting work. They il-
lustrate species differences as well as substrate specificity and dif-
ferences in the hepatic monooxygenase activities of 2 strains of pine 
voles and white mice. 
Brindley (1979) saw varying effects on hepatic monooxygenase ac-
tivities in Microtus canicaudus, the grey-tailed vole. The inductive 
effects on £-nitroanisole-Q-demethylase and aniline hydroxylase varied 
depending on the inducer pretreatment of either phenobarbital or 
B-naphthoflavone. 
Makary (1981) characterized biphenyl hydroxylation in hepatic 
microsomes of Microtus montanus (mountain vole). This activity was 
compared to biphenyl hydroxylation seen in Swiss white mice. In the 
control animals, 4-hydroxybiphenyl was the major metabolite in both 
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species, but all the Qydroxy metabolites were produced in higher con-
centrations in the mice than in the voles. Pretreatment with pheno-
barbital (PB) showed significant increases of 2-, 3-, and 4-hydroxybi-
phenyl in the mountain voles. Mice showed an inducti on in 3- and 4-
hydroxybiphenyl with treatment of PB . Voles pretreated with 
B-naphthoflavone or 3-methycholanthrene showed slight increase of all 
3 metabolites, whereas mice showed higher induction in 2-hydroxybi-
phenyl over 3- and 4-hydroxylation. The results of this study showed a 
definite species difference between white mice and mountain voles in 
their hepatic monooxygenase system. 
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MATERIALS AND METHODS 
Animals 
Female Microtus montanus (mountain vole) 8-12 weeks of age, were 
obtained from the Department of Biology, University of Utah, Salt Lake 
City, Utah. The animals were kept at the Utah State University animal 
care facility, 5 voles per plastic cage containing wood chips and cotton 
batting. The voles were acclimatized for at least 7 days to the housing 
conditions of 20°C and a 12-hour photoperiod per day. Intermountain 
Farmers Association rabbit pellets and water were provided ad libitum. 
Chemicals 
Pretreatment compounds 
Sodium phenobarbital, crystalline powder, was obtained from Merck 
& Co., Inc. (Rahway, N.J.) and dissolved in 0.85% NaCl. B-naphtho-
flavone was purchased from Aldrich Chemical Co. (Milwaukee, WI), and 
Aroclor 1254 from Analabs (North Haven, Conn.). Both compounds were 
dissolved in Wesson vegetable oil. 
Protein and liver enzyme assays 
Coomassie Brilliant Blue G, used for the protein assay, and bovine 
serum albumin used in the standard curve, were supplied by Sigma 
Chemical Co. (St. Louis, Mo). NADP+, NADPH, cytochrome C (prepared 
from horse heart), sodium D, L~isocitrate, isocitrate dehydrogenase, 
p-nitrophenol spectrophotometer standard, and Tris buffer (pH 7. 7) were 
also obtained from Sigma Chemical Co. (St. Louis, Mo). Aniline 
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analytical reagent and sodium hydroxide were purchased from Mallinckrodt 
Chemical Works (St. Louis, Mo), and trichloroacetic acid was obtained 
from Fisher Scientific Co. (Fair Lawn, NJ). J. T. Baker (Phillipsburg, 
NJ) supplied _p-nitroanisole, _2-aminophenol, potassium cyanide, crystal-
line phenol, sodium carbonate, and magnesium chloride. 
Serum enzyme assays 
Alcohol dehydrogenase, B-NAD, a -hetoglutaric acid, _p-iodonitrote-
trazoluim violet, pyruvic acid, and the chemicals used in the buffer 
solutions were purchased from Sigma Chemical Co. (St. Louis,' Mo). 
Aldrich Chemical Co. (Milwaukee, WI) supplied 2,-3 -dinitrophyl-
hydrozine. Benzene and d,l-alanine were obtained from Fisher Scienti-
fic Co. (Fair Lawn, NJ). The other solvents used in the column and 
thin layer chromatography procedures were purchased from J. T. Baker 
Chemical Co. (Phillipsburg, NJ). Technical malathion 94.2% pure was 
donated by the American Cyanamid Co. (Princeton, NJ). 
Hepatic Enzyme Assay Procedure 
Voles received intraperitoneal injections of either sodium pheno-
barbital (PB) in 0.85% saline solution, B-naphthoflavone (BNF) dis-
solved in oil or Aroclor 1254 (PCB), also in oil. Levels of pre-
treatment for PB groups ranged from 5 mg/kg body weight up to 100 mg/kg, 
whereas BNF and PCB groups ranged from 5 mg/kg to 80 mg/kg. The dosing 
schedule consisted of 3 injections, 24 hours apart with a solution 
volume of 10 ml/kg body weight. The animals were sacrificed 24 hours 
after the last injecti.on of PB and 48 hours for BNF and PCB. The re-
sults of the treatments were compared to control animals that received 
the same number of injections of saline or oil only. Food and water 
were allowed ad libitum throughout the pretreatment schedule, until 
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time of sacrifice. To prevent any fluctuations in enzyme activity due 
to circadian rhythm, the injections and sacrificing occurred at the same 
time between 8 and 10 a.m. 
Liver microsomal preparation 
Microsomes were prepared by the methods of Hartgrove et al. (1977). 
The voles were sacrificed by decapitation. Gall bladders were cut away 
and livers were removed, weighed, checked grossly for pathological signs, 
and placed in small beakers surrounded by ice. The remainder of the 
liver preparation occurred on a cold table keeping the temperature be-
tween 0-4°C. Livers were minced with a razor blade and homogenized in 
5 ml of cold 1.15% KCl. The homogenate was brought to a volume of 12 ml 
with the KCl, and the cells were further disrupted using a Biosonik III 
sonicator (Bronwill Scientific, Rochester, NY). The homogenate received 
three 5-second bursts at the 10-W setting with 15-seconds between each 
burst. The homogenate was centrifuged at 9,000 g for 20 minutes and 
the supernatant was run at 30,000 rpm (105,000 g) for 75 minutes. 
Centrifugation was performed in a Beckman L5-65B refrigerated ultra-
centrifuge with a type-30 rotor. The microsomal pellet was washed with 
1 ml 1.15% KCl in 0 . 02 M Tris buffer (pH 7.7) and resuspended in 5 ml of 
the same buffer by gentle homogenization. 
Protein determination 
Protein levels were measured by the method of Bradford (1976). 
The protein reagent consisted of 100 mg Coomassie Brilliant Blue G and 
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50 ml 95% ethanol shaken for at least 2 hours. After shaking, 100 ~l 
85% phosphoric acid was added and the solution was diluted with water to 
a final volume of 1 liter. The protein reagent was filtered before each 
use. Standard curves were constructed for each reagent mixture, using 
known concentrations of bovine serum albumin. 
The resuspended microsomes in 5 ml of Tris-KCl buffer (pH 7.7) were 
diluted by taking 1 ml and bringing it up to a volume of 4 ml with the 
Tris KCl buffer for a final dilution of 1:20. Each microsome sample 
was further diluted 20, 25 and 30 fold with Tris KCl buffer. Aliquots 
of 0.05 ml of these 3 dilutions were placed in separate test tubes. 
Each tube received 5 ml of filtered Coomassie Blue reagent and mi xed 
gently. As a result, each liver sample was read in triplicate for pro-
tein at three different concentrations. 
The absorbance was measured after 2 minutes and before 1 hour on 
a Zeiss PMQ-11 spectrophotometer set at 595 nm and slit width 0.07. 
Samples were read against a standard consisting of 0.5 ml Tris buffer 
and 5 ml protein reagent. The optical densities were converted to pro-
tein concentrations using the standard curve. 
Aniline hydroxylase assay 
The microsomal activity of aniline hydroxylase was determined by 
the formation of p-aminophenol as described by Imai et al. (1966). 
This method was easier to run and involved less time than the ether ex-
traction procedure by Kato and Gillette (1965). Chhabra et al. (1972) 
demonstrated that Imai 1 s method provides higher recovery of p-amino-
phenol when liver microsomes are used as an enzyme source compared to 
the ether extraction procedure. 
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A suitable volume of the 1:5 dilution microsome solution was used 
to obtain a protein level between 0.6 to 1.2 mg protein per incubation. 
This provided a linear relationship between protein concentration and 
rate of reaction. The volume of the tissue solution was placed in a 
test tube and brought up to 0.6 ml with 1.15% KCl in 0.02 M Tris buffer 
(pH 7. 7). Added to this was 0.2 ml of the NADPH-generating system. 
The reaction was started by adding 0.2 ml of an aniline stock solution 
making the final volume of the reaction mi xture 1 ml, and containing 
8 m moles of aniline. The reaction was carried out for 20 minutes at 
37 °C in a water bath with moderate shaking and stopped by the addition 
of 0.5 ml cold 20% trichloroacetic acid. Each sample was run in tripli-
cate. 
The mi xture was centrifuged at 2,000 rpm for 5 minutes and 1 ml 
aliquot of the supernatant was removed. To this was added 0.5 ml 10% 
Na 2C0 3 followed by 1 ml 2% phenol in 0. 2 N NaOH. The resulting blue 
color was measured after 30 minutes on the Zeiss PMQ-11 spectrophoto-
meter set at 630 nm, and slit width 0.15. The absorbance was measured 
against a cuvette containing only Tris-KCl buffer. The optical densi-
ties were compared to the standard curve constructed from known amounts 
of .2_-aminophenol. 
Each 1 ml of NADPH generating system contained stock solutions of 
0.32 ml MgClz•6H20 (0.4g. in 100 ml),0.32 ml sodium DL-isocitrate 
(0.9gin 100 ml), 0.0182 ml isocitrate dehydrogenase, 0.00056 g NADP+, 
and enough water to bring it up to the volume of l ml. The system was 
checked for the production of NADPH by the increase in optical density 
c1 t 340 nm 
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~-Nitroanisole-0-demethylase assay 
p-Nitroanisole-0-demethylase activity was measured by the formation 
of p-nitrophenol by the methods of Kinoshita et al. (1966). The stock 
solution of p-nitroanisole (PNA) contained 0.07 g PNA in 2 ml 100% 
ethanol and 8 ml ethylene glycol. The glycine buffer solution contained 
0.5 M glycine titrated to pH 9.4 with saturated Na0H. 
For each liver sample,0.05, 0.1 and 0.2 ml of the 1:20 dil tissue 
solution were put in 3 test tubes. Each tube was brought up to 0.4 ml 
with 1.15% KCl in 0.02 M Tris buffer and 0.2 ml NADPH generating system 
was added. The NADPH generating system used for aniline hydroxylase 
was also used for the PNA assay. A volume of 0.5 ml stock PNA solution 
was mixed with 5 ml of the Tris-KCl buffer and remained warm in a 37°C 
water bath. This prevented any precipitation of the substrate PNA. 
The reaction started when 0.2 ml of the warm PNA was added to each test 
tube. The mixture incubated for 15 minutes at 37°C with moderate shaking. 
Cold acetone, 2.5 ml, was added to each tube to stop the reaction. The 
tubes were corked and allowed to reach room temperature. 
Each tube received 0.2 ml of the glycine buffer solution and the 
precipitates were separated by centrifuging at 2,000 rpm for 10 minutes. 
The yellow color was read at 410 nm on the Zeiss spectrophotometer and 
slit width 0.15. The absorbance was measured against distilled water 
and the optical density was converted to concentration of p-nitrophenol 
using a standard curve. 
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Cytochrome C reductase assay 
Hepatic microsomal cytocrome C reductase activity was measured by 
the modification of the method of Dallner (1963). For every 4 assays, 
8.712 mg of cytochrome C and 0.95 mg of NADPH were dissolved in 8 ml 
1.15% KCl in 0.02 M Tris buffer (pH7.7). KCN, 0.304 mg, was dissolved 
in 4 ml Tris KCl buffer. These 2 stock solutions were made just prior 
to running the assay. 
The procedure consisted of pipetting 0.05, 0.1 and 0.2 ml of the 
1:20 tissue dilutions into 3 test tubes. These tubes were brought to 
a volumeof0.5 ml with Tris KCl buffer. A volume of 1.0 ml KCN stock 
solution was added to each tube. Just prior to reading a sample, 2 ml 
of the cytochrome C and NADPH solution were added to the test tube. The 
production of reduced cytochrome C was observed on the Zies spectro-
photometer (550 nm). Optical densities were recorded at time 0, 10, 20 
and 60 seconds. The concentration of reduced cytochrome C was calcu-
lated by using Beer's Law and the extinction coefficient of 21000 cm3/M 
at 550 nm . 
Serum Enzyme Assay Procedure 
Female voles received the same pretreatment schedule as described 
under the hepatic enzyme assay procedure. A high, low and middle dose 
were used for each chemical except carbon tetrachloride. The doses in-
cluded 5, 50, or 80 mg/kg body weight of sodium phenobarbital. B-
Naphthoflavone and Aroclor 1254 were given at 5, 40, or 80 mg/kg. 
Carbon tetrachloride was given by 1 injection of 0.1 ml /kg. Results 
were compared to controls of oil or saline. The animals were sacrificed 
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and blood collected by decapitation. Gall bladders were removed, livers 
weighed and gross appearance noted. A section from the lower left lobe 
of the liver was placed in 10% neutral buffered formalin for histopath-
ology examination. 
Serum was collected by leaving the blood at room temperature for 
1 hour, then refrigerated for 30 minutes, followed by centrifuging on 
a Triac centrifuge, ~lay Adam~ for 5 minutes. Serum volumes collected 
varied from 0.2 ml to 0.4 ml. The serum samples were diluted 1:5 for 
the serum transaminase assay using 0.1 M phosphate buffer (pH 7.4). A 
dilution of 1:100 for malathion carboxylesterase and 1:1,000 for the 
protein assay was achieved by adding 0.1 M Tris HCl buffer (pH 7.5). 
Protein determination 
Protein of serum samples was determined by the method of Bradford 
(1976). The samples were diluted 1:1,000 with the 0.1 M Tris HCl buffer 
(pH 7.5) and 0.05 ml of this solution was mixed with 5 ml of the protein 
reagent. Each sample was run in triplicate. The rest of the procedure 
was the same as outlined under the protein determination for hepatic 
microsomes. 
Serum glutamic pyruvic transaminase 
In this reaction, an amino group from alanine is transfered to 
a-ketoglutaric acid to form glutamic acid and pyruvic acid. The assay 
was conducted by the methods of Reitman and Frankel (1957). The volumes 
used in the assay were 1/2 that described by Reitman because of the 
small quantities of serum obtained. There was no change in enzyme 
activity due to this reduction of the reactants. 
The 0.1 M phosphate buffer system (pH 7.4) was prepared by mixing 
420 ml 0.1 M disodium phosphate with 80 ml 0.1 M potassium dihydrogen 
phosphate. The substrate solution consisted of 2 mM a-ketoglutarate 
and 200 mM Q}_-alanine brought to volume with the phosphate buffer. 
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The substrate solution, 0.5 ml, was incubated with 0.1 ml of the 1:5 
diluted serum for 30 minutes at 40°C with mild shaking. The substrates 
were warmed in the water bath for 10 minutes prior to the start of the 
reaction. The reaction was stopped by adding 0.5 ml of 12, 4-dinitro-
phenylhy~razine. The mixture remained at room temperature for at least 
20 minutes before 5 ml of 0.4 N sodium hydroxide was added. At the 
end of 30 minutes, the optical density was measured at 505 nm on the 
Ziess spectrophotometer with the slit width 0.04; using water as a 
blank. 
A control for each serum sample was prepared by mixing 0.5 ml 
substrate, 0.1 ml dilute serum, and 0.5 ml of the hydrazine reagent. 
After a minimum of 20 minutes, 5 ml of 0.4 N sodium hydroxide was added 
and the optical density of the solution was measured as mentioned with 
the incubated mixture. 
The change in optical density was calculated by subtracting the 
optical densities of the control value from the corresponding incubated 
value. This change in optical density was converted to micromoles of 
pyruvate using the prepared standard curve. This value was then 
converted to units of transaminase activity, using the standard curve 
supplied by Reitman and Frankel (1957), which was based on the units 
described by Karmen (1955}. This is sho~n in Fi~. 2. 
The standard curve plotting change in optical density against 
micromoles of pyruvate, was prepared by mixing known amounts of 2 mM 
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a-ketoglutorate solution and 2 mM pyruvate solution, making a total 
concentration of keto acid, to be 2 mM per 1 ml. Added to this was 0.1 
ml water; the hydrazine reagent and alkali were added as described in 
the procedure above. 
Malathion carboxylesterase 
Serum malathion carboxylesterase assay was based on the methods of 
Talcott (1979). Malathion is hydrolyzed to form malathion monoacid and 
ethanol. Alcohol dehydrogenase converts the ethanol and NAO to aceta-
ldehyde and NAOH. The NAOH plus diaphorase reduced .e_-iodonitrophenyl-
tetrazolium violet (INT) and this reduction could be measured spectro-
photometrically. 
The reduction of INT was measured at 500 nm on the Ziess PMQ-11 
spectrophotometer. Water was heated and passedaroundthesample chamber 
to keep the chamber at 37°C during the incubation. The assays were 
done in cuvettes containing 2.5 ml of incubation mixture. This mixture 
contained 0.6 ml of the 1:100 diluted serum, making a final dilution in 
the reaction to be 1:4175. The serum and other reactants were in a 
0.1 M Tris HCl buffer (pH7.5). The incubation mixture also contained 
437 Ug/ml INT, 25 U/ml alcohol dehydrogenase, 1.8 mM NAO, and 0.1 
U/ml NAO diaphorase. The reactions were started by injecting 5 ul of 
150 mM malathion (in acetone) into the cuvette and mixed by inversion. 
The incubation mixture began reacting after 2 minutes in the 37°C 
temperature. The change in optical density was recorded every 30 sec-
onds for the next 3 to 4 minutes. The malathion carboxylesterase 
activity, equivalent to the INT reduction rate, was calculated using 
Beer's law and the extinction coefficient of 0.01375 A500/µM as 
determined by Talcott (1979). 
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The malathion used for the assay was purified by column chroma-
tography by the modified methods of Pellegrini and Santi (1972). The 
column chromatography was performed in a glass column (inside diameter 
2 cm,height 45 cm), eluting malathion with 90:10 n-hexene:acetone. 
Malathion was eluted in the 160 to 240 ml fraction. The column was 
packed with 40 g of silica gel 60 from MC/B Manufacturing Chemists, 
Inc. (Cincinnati, OH), having a mesh of 70-230. 
The above procedure increased the purity of malathion to 98.2% 
pure (Pellegrini and Santi, 1972). This was checked by thin layer 
chromatography using the methods of Umetsu et al. (1977). Precoated 
plates of Kontes Chromaflex Q6F measuring 5 x 20 cm were used with 
ben ze ne. The l ocation of the compounds were determined by ultravi olet. 
Most of the impurities were removed by the column chromatography, 
with only small quantities remaining. This corresponded to the RF 
(0.5-0.55) of (CH 3 □) 2 P(S)SP(S) (OCH 3)2 as found in Umetsu et al. 
(1977 ). This compound had little interference if any in the malation 
carb ox ylestaerase assay. 
Hepatic Histological Procedure 
Tissues used for the histopathology were kept in 10% neutral 
buffered formalin until needed for sectioning. The histological 
slides were prepared by the Veterinary Diagnostic Laboratory (log 
number L82-1401) and stained with hemato xylin and eosin. The 
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General Effects on Animals and Livers 
Animals pretreated with phenobarbital (PB) in the 20 and 50 mg/kg 
range, appeared sedated while 5 mg showed no effects and 80 and 100 
mg induced sleep. Aroclor 1254 (PCB) and B-naphthoflavone (BNF) showed 
no adverse behavioral effects. Carbon tetrachloride-treated animals 
at doses of 1 or 2 ml/kg died, while 0.1 ml/kg caused lethargy 
and the animals were severely stressed due to the to xicity of the 
compound. 
Average body weights and liver weights of PB, BNF, and PCB and 
the control animals are shown in Table 1. The ratio of liver weight 
t o body weight increased significantly (P<0.01) in the higher doses of 
PB and 80 mg PCB over the controls of saline and oil respectively. No 
significant difference (P< 0.01) was seen in the BNF pretreatment 
groups compared to oil (Table 1). The ratio of microsomal protein to 
liver weight varied according to type of inducer and dose of pretreat-
ment as illustrated in Table 1. 
Effect of Hepatic Microsomal Enzymal Activity 
by PB, BNF and PCB 
The mean changes in microsomal enzyme activity of aniline hydroxy-
lase, £-nitroanisole-_Q_-demethylase and cytochrome C reductase are shown 
in Table 2. The enzyme activity varied according to the type of inducer 
and the pretreatment dose. Following Table 2, the results are grouped 
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Table 1. Effect of pretreatment injection upon liver weights, liver 
weight to body weight and microsomal protein of female voles. 
mg 
Microsomal 
Pretreatment Body Wt. Liver Wt. mg Liver/ Protein/ 
mg/kg n (g) ( g) g Body Wt. g liver 
Control 5 28.2 ± 3.6 1.10 ± 0.37 38. 5 ± 9.5 33.7 ± 3.7 
Saline 8 30.0 ± 3.2 1.09 ± 0.16 35.9 ± 6.1 25.1 ± 2.5* 
PB 5 5 34.7 ± 3.8 1.44 ± 0.30 41.3 ± 7.1 22.8 ± 4.7 
20 4 31. 9 ± 4.8 1.42 ± 0.36 45.0 ± 11.9 21. 7 ± 6.4 
50 5 33.8 ± 8.3 1.61 ± 0.54 47.0 ± 4.7* 36.3 ± 3.9* 
80 4 38.0 ± 8.9 1.87 ± 0.52 48.8 ± 3.3* 33.7 ± 3.5* 
100 5 25 .8 ± 3.5 1.58 ± 0.38 60.8 ± 7.9* 32.1 ± 3. 6* 
OIL 5 25.3 ± 2.7 0.82 ± 0.06 32.6 ± 2.8 25.4 ± 2.8* 
BNF 5 5 33.5 ± 11.4 1.25 ± 0.28 38.5 ± 7.1 16.8 ± 1.4* 
20 5 29.3 ± 3.2 0.98 ± 0.16 33.4 ± 2.7 12.3 ± 2.6* 
40 5 25.3 ± 4.0 0.84 ± 0 .11 33.3 ± 2.4 23.3 ± 3.6 
50 4 35.8 ± 9.5 1.23 ± 0.43 33.9 ± 2.9 27.9 ± 4.7 
80 5 30.4 ± 2.0 1.06 ± 0.07 34.9 ± 2.3 15.8 ± 3.3* 
PCB 5 5 29.4 ± 4.4 0.84 ± 0.16 28.7 ± 3.5 23.9 ± 2.5 
10 5 31.4 ± 6.0 1.10 ± 0.19 35.3 ± 3.3 22.0 ± 2.3 
20 5 27.9 ± 1.6 0.87 ± 0.12 31.3 ± 4.2 27.5 ± 2.2 
40 5 29.7 ± 3.8 1.15 ± 0 .13 39.6 ± 8.7 27.5 ± 5.9 
80 5 31. 9 ± 1.2 1.25 ± 0.17 39.1 ± 4.1* 23.0 ± 6.8 
Results are mean ± standard deviation. 
*Indicates significant difference ( p < 0. 01 ) • 
Table 2. Variation in enzyme activity due to type and does of in-
ducer in voles. 
Pretreatment Aniline p-Nitroani sole Cytochrome C 
mg/kg n Hydroxylase* -=-_g_-demethylase* Reductase** 
Control 5 0.056 ± 0.005 0.052 ± 0.01 84.8 ± 10 .1 
Saline 8 0.046 ± 0.015 0.038 ± 0.015 83.0 ± 15.7 
PB 5 5 0.066 ± 0 .013 0.058 ± 0.008 111. 5 ± 11.8 
20 5 0.132 ± 0.04 0.063 ± 0.02 162. 81 ± 37 
50 5 0.126 ± 0.009 0.074 ± 0.011 121. 3 ± 6.8 
80 4 0.177 ± 0.030 0.105 ± 0.013 143 .6 ± 26.5 
100 5 0.138 ± 0.020 0.145 ± 0.032 228 .1 ± 19. 8 
0 i l 5 0.0631 ± 0.010 0.059 :!: 0.016 97 . 4 ± 18. 5 
BNF 5 5 0.067 ± 0.018 0.034 ± 0.012 147 . 1 ± 28.5 
20 5 0.073 ± 0.047 0.055 ± 0.010 260.7 ± 80.8 
40 5 0.087 ± 0 . 015 0.072 ± 0.014 130.4 ± 19.8 
50 4 0.087 ± 0.025 0.061 ± 0.022 88.5 ± 26. 8 
80 5 0.095 ± 0 .032 0.095 ± 0.023 153.4 ± 27 .8 
PCB 5 5 0. 085 ± 0.019 0.045 ± 0 .011 124.0 ± 13.3 
10 5 0.046 ± 0.004 0.082 ± 0.014 102. 7 ± 13.0 
20 5 0.075 ± 0.015 0.069 ± 0.005 97.3 ± 10.5 
40 4 0.058 ± 0.013 0.038 ± 0.013 84.4 ± 19.9 
80 4 0.077 ± 0.026 0.050 ± 0.005 93.3 ± 9.8 
Results are mean ± standard deviation 
* Indicates µ moles/mg protein - min. 
** Indicates n moles/mg protein - hr. 
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by the different substrates used to determine monooxygenase activity. 
Graphical respresentation of the enzyme activity for the 3 inducers at 
various doses, is followed by a table illustrating the significant dif-
ferences. The lines in the graph are smoothed to pass through each mean 
activity value at the corresponding dose of inducer. The significant 
differences of enzyme activity in the same pretreatment group, but 
varying the dose; and the differences between the inducers at the same 
dose were calculated by multi-way AN0VA (P < 0.05). In the AN0VA 
tables, (+) indicates a significant difference while (-) indicates no 
significant difference at P < 0.05. Increase and decrease differences 
are represented by I and D respectively. The increase and decrease are 
determined by the change in activity of the pretreatment dose on the 
horizontal axis compared to dose on the vertical axis. 
Aniline hydroxylase 
Figure 3 illustrates the change in enzyme activity of aniline hy-
droxylase, due to the dose of inducer PB, BNF, or PCB. PB shows an 
increase at the dose of 20 mg/kg and leveling off until a dose of 80 
mg/kg increases the activity. Significant differences (SD) are shown 
in Table 3, and support the plateau effect since 20 and 50 mg/kg are SD 
over the control and 5 mg; yet no SD occured between 20 mg and 50 mg. 
The dose of 80 mg of PB causes a significant increase in activity over 
all the lower doses while 100 mg/kg decreases activity compared to 80 
mg and is not SD from 20 or 50 mg/kg. 
BNF shows a slow, steady increase of enzyme activity with in-
creased pretreated doses (Figure 3). But these activities are not SD 
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Table 3. Results of ANOVA in microsomal enzyme activity of aniline 
hydroxylase. 
I. No significant difference between control, saline, or oil. 
I I. Differences in same pretreatment groups varying the dose: 
PB 5 mg 20 mg 50 mg 80 mg 100 mg 
Saline +I +I +I +I 
PB 5 mg +I +I +I +I 
20 mg +I 
50 mg +I 
80 mg +D 
BNF no significant differences in varying the dose. 
PCB no significant differences in varying the dose. 
III. Differences between the 3 pretreatment groups of the same dose: 
5 mg; no significant differences 
20 mg; no significant differences 
40 + 50 mg; PB 50 (+I) over BNF 40 which is (+I) over PCB 40 
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80 mg; PB 80 (+I) over BNF 80 and PCB 80; but no significant 
difference between BNF 80 and PCB 80. 
(+) indicates significant difference (P < 0.05) 
(-)indicates no significant difference (P < 0.05) 
I -- increase; D -- decrease; I and Dare determined by comparing the 
results of the horizontal axis pretreatments to the vertical. 
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showed fluctuation as seen in Figure 3, yet the activities were not SD 
determined by AN0VA (Table 3). 
Differences between the 3 inducers on aniline hydroxylase activity 
at the same dose level were calculated and results shown in section III 
of Table 3. PB at 50 mg caused an increase SD of enzyme activity over 
BNF at 40 mg which was also SD over PCB at 40 mg. PB of 80 mg pre-
treatment was significantly higher than the effect of BNF and PCB at 80 
mg, but no differences between BNF and PCB at 80 mg. 
_g-~li troani so 1 e-_Q_-demethyl ase ( PNA) 
The changes in PNA activity are illustrated in Figure 4 with the 
ANOVA shown on the following page in Table 4. The effects of increasing 
the dose of PB pretreatment caused an increase in PNA activity. 
Starting at the dose of 20 mg/kg and continuing up to 100 mg/kg, all 
the doses were significantly different (SD) from controls and each 
higher dose was SD than the lower doses (Table 4). 
Pretreatment with BNF at 5 mg/kg led toa significant decrease i n 
activity over the control, whereas 20, 4G, and 50 mg/kg were not SD 
from the controls. This is shown in Figure 4 and Table 4. Pretreat-
ment of 80 mg/kg of BNF produced a significant increase in PNA activity 
over controls and all lower doses. 
PCB pretreatment resulted in a significant increase in hydroxylase 
activity at low doses of 10 and 20 mg/kg, but a significant decrease in 
activity at 40 and 80 mg/kg. Although, 80 mg/kg was not SD over the con-
trol, it was SD compared to dose levels of 10 and 20 mg/kg. 
At the level of 5 mg/kg, BNF had an effect of decreasing PNA ac-
tivity which is SD over the effects of PB and PCB. There was no SD 
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Table 4. Results of ANOVA in microsomal enzyme activity of 
..e_-nitroanisole-Q-demethylase. 
I. No significant differences between control, saline, and oil. 
II. Differences in same pretreatment groups varying the dose: 
PB 
Saline 




























































III. Differences between the 3 pretreatment groups of the same dose: 
5 mg; BNF (+D) compared to PB and PCB. 
20 mg; no significant differences. 
40 + 50 mg; PB 50 and BNF 40 are both (+I) over PCB 40. 
80 mg; PB and BNF are both (+I) over PCB. 
(+) indicates significant difference (P < 0.05) 
(-) indicates no significant difference (P < 0.05) 
I -- increase, D -- decrease; I and Dare determined by comparing the 
results of the horizontal axis pretreatments to the vertical. 
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ment of PB at 50 mg/kg and BNF at 40 mg/kg produced a significant in-
crease in PNA activity over PCB at 40 mg/kg. Again, at 80 mg/kg, the 
effects of PB and BNFwere significantly higher than the effects produced 
by PCB. 
Cytochrome C reductase 
Figure 5 illustrates the effects of PB, BNF, and PCB at various 
doses, on cytochrome C reductase activity. Table 5 shows the ANOVA of 
the reductase activity. PB produced a significant increase in activity 
at all pretreated doses, compared to control. The effect on the reduc-
tase activity increased except at 50 and 80 mg/kg which were significant-
ly depressed compared to 20 mg. Then at 100 mg/kg, the activity was 
significantly higher then all the other doses. 
The effects of BNFwere similar to that of PB. The low doses of 
5 and 20 mg/kg produced an increased SD over the controls as well as the 
80 mg/kg treatment. But the intermediate dose of 40 and 50 mg/kg pro-
duced an effect that is not SD than the control. The highest reductase 
activity with BNF pretreatment occured at 20 mg/kg. 
Pretreatment with PCB showed a significant increase in reductase 
activity at the level of 5 mg/kg only. PCB doses of 10, 20, 40, and 
80 mg/kg showed a difference in effect over control, yet each dose sig-
nificantly depressed reductase activity compared to 5 mg/kg PCB. 
At the level of 5 mg/kg, the reductase activity of BNF pretreat-
ment, was significantly higher than the effect of PB, as shown in Table 
5, section III. Pretreatment at the 20 mg/kg dose showed BNF to be SD 
over PB, which was SD over PCB. PB at the dose of 50 mg/kg and BNF at 
40 mg/kg produced a significant increase in reductase activity over PCB 
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Figure 5. Effects of inducer dose on cytochrome C reductase activity. 
45 
Table 5. Results of ANOVA in microsomal enzyme activity of cytochrome 
C reductase. 
I. No significant differences between control, saline, and oil. 
II. Differences in same pretreatment groups varying the dose: 
PB 
Saline 



























































III. Differences between the 3 pretreatment groups of the same dose: 
5 mg; BNF (+I) over PB only. 
20 mg; BNF (+I) over PB which is (+I) over PCB 40. 
40 + 50 mg; PB 50 and BNF 40 both (+I) over PCB 40. 
80 mg; PB and BNF both (+I) over PCB. 
(+) indicates significant difference (P < 0.05). 
(-) no significant difference (P < 0.05). 
I -- increase, D -- decrease; I and Dare determined by comparing the 
results of the horizontal axis pretreatments to the vertical. 
5). 
Percent change of hepatic enzyme activity 
compared to control 
The data from PB, BNF, and PCB effects on hepatic microsomal 
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enzyme activity in Table 2 were compared to the corresponding control 
values. The percent change in activity due to the dose and type of in-
ducer is presented in Table 6. Figures 6-8 are graphical representation 
of the results from Table 6. These graphs indicate the trends of in-
duction potential of PB, BNF, and PCB at various doses on: aniline 
hydroxylase, ~-nitroanisole-Q-demethylase and cytochrome C reductase. 
Aniline hydroxylase activity increased to 171-185% over the con-
trol at the medium range doses of 20 and 50 mg/kg PB; with 80 mg/kg PB 
caused a 282% increase in activity. BNF produced a slight increase in 
hydroxylase activity at each higher dose, while 80 mg BNF caused a small 
50% change over control. The percentage change that PCB produced, was 
minimal compared to control values (Figure 6). 
For p-nitroanisole-0-demethylase, PB produced an increase in per-
- -
cent change over control with each higher dose, showing 80 mg/kg PB to 
cause a 174% increase (Figure 7). Pretreatment of 5 mg/kg BNF caused 
a 44% decrease in activity while 80 mg resulted in a 60% increase. The 
percent change in demethylase activity due to PCBwassmall;whil ,2 5, 40, 
and 80 mg/kg levels produced a decrease. 
Figure 8 shows the percent change from controls for cytochrome C 
reductase activity. PB produced an increase in percent change with the 
highest increase, 96%, occuring at 80 mg/kg. BNF generated small per-
cent changes except at 20 mg/kg where the activity increased 168% over 
the controls. PCB created a decrease in percent change, except for the 
Table 6. Percent change from control of enzyme activities at various 
pretreatment doses in voles. 
Percent change from control 
Pretreatment Aniline .E_-nitroanisole Cytochrome C 
(mg/kg) Hydroxyl ase -_Q-demethyl ase Reductase 
PB 5 43 50 34 
20 185 63 (.;, 96 
50 171 93 46 
80 282 174 73 
BNF 5 6 -44 51 
20 15 - 8 I}..- 168 
40 38 22 34 
50 38 3 -9 
80 51 60 58 
PCB 5 34 -24 27 
20 20 16 - 1 
40 - 8 -36 -13 
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Figure 6. Percent change of pretreated animals from controls for aniline hydroxylase. 
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figore 8. Percent change of pretreated animals from controls for cytochrome C reductase. 
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low dose of 5 mg/kg. 
Serum Enzyme Levels of SGPT and 
Malathion Carboxylesterase 
51 
Table 7 shows the results of serum glutamic pyruvic transaminase 
(SGPT) and malathion carboxylesterase U1CE) levels due to pretreatment 
of PB, BNF, and PCB at low, medium and high doses. There was no sig-
nificant difference (SD) between the controls, saline, and oil in either 
SGPT or MCE. Table 7 also illustrates the .high variability in SGPT 
levels. PB at 5 mg/kg, 80 mg/kg of BNF, and 5 and 40 mg/kg of PCB all 
produced a significant decrease in SGPT units (P < 0.05). Pretreatment 
with 80 mg/kg PB and 5 and 40 mg/kg BNF produced a significant decrease 
in SGPT units (P < 0.1 ). MCE levels significantly decreased (P < 0.01) 
with pretreatment doses of 5 and 50 mg/kg PB and 40 mg/kg PCB. Carbon 
tetrachloride, injected once, at O.l ml/kg produced a massive in-
crease in SGPT units and serum MCE activity. Rats, with no pretreat-
ment, showed significantly higher levels (P < 0.05) of SGPT and MCE, 
compared to the vole control group. 
Gross Evaluation and Histopathology 
of Liver Tissues 
Samples of control liver tissues (no pretreatment) appeared normal 
with well delineated sinusoids (Figure 9). Gross examination showed 
saline injected voles appeared normal while the livers from the oil 
group were greasy. Histological evaluation revealed swelling and 
slight vacuolization of hepatocytes diffusely throughout the lobule in 
the saline group (Figure 10), with increased vacuolization in the oil 
Table 7. Serum enzyme levels of SGPT and malathion carboxylesterase 





mg/kg n SGPT Units n mg Prat-min 
Control 4 99.5 ± 17.3 4 4.99 ± 2.6 
Saline 4 96 .3 ± 45.9 4 4.0 ± 2.4 
PB 5 3 30.0 ± 13.2** 4 7. 8 ± 3.9* 
50 4 65.0 ± 21.2 4 9.9 ± 1.2* 
80 2 39.0 ± 4.2* 4 4.7 ± 1. 9 
OIL 4 60.0 ± 24. 8 4 8.8 ± 5.1 
BNF 5 4 37.5 ± 17.1 2 11. 6 ± 0.7 
40 3 31. 7 ± 12.6 2 4.6 ± 2.9 
80 4 31.3 ± 8.5** 4 8.7 ± 6.4 
PCB 5 3 6.7 ± 1.2** 2 7.2 ± 4.2 
40 3 8.2 ± 1.9** 3 4 .1 ± 2.3 
80 2 36.0 ± 0 3 7.4 ± 3.9 
Carbon 
Tetrachloride 4 1475 ± 275.4** 4 17.92 ± 3** 
0.1 ml/kg 
Rat -- no 
pretreatment 2 157.5 ± 116.7 2 23.9 ± 0.6 
Results are mean ± standard deviation. 
*Indicates significant difference ( p < 0.10). 
**Indicates significant difference ( p < 0.05). 
Figure 9. Light micrograph of hepatic tissue from voles with no 
pretr atment. 




injected voles. The sinusoidal spaces were not as apparent compared to 
the controls. 
In general, the histological changes seen from the different in-
ducers and dose levels were similar. Cellular responses included acute 
degeneration with lipid accumulation and vacuolated cytoplasm, primar-
ily in the centrilobular regions. No inflarm1atory responses were seen 
in the hepatic tissues. Using a system for ranking the tissue lesion 
did not prove feasible because of the variations seen within the dif-
ferent dose levels. Comments on the general trends of the liver changes 
between the inducers and dose levels are presented below. 
Gross examination of the PB treated voles showed no changes in the 
5 mg/kg group, while the 50 and 80 mg dosed animals had enlarged livers. 
Histological examination showed increased foamy and vacuolated centri-
lobular hepatocytes at the 5 mg/kg level. This spread into the midzon-
al regions and increased in intensity with the 50 mg/kg groups (Figure 
11). At the highest dose of 80 mg/kg, some hepatic tissues appeared 
similar to the 50 mg group; while other samples showed less vacuolation 
and most cells becoming hypertrophied with enlarged nuclei. This is 
shown in Figure 12. 
The livers from BNF treated voles, under gross examination, were 
greasy in appearance at the 5 mg/kg dose with enlarged livers and 
fibrin tabs present in the 40 and 80 mg dosed animals. Histologically, 
the livers appeared similar to that of PB pretreatment except the 
changes did not follow at the same dose levels. At the 5 mg/kg BNF 
pretreatment group, some samples showed little change from the controls 
and others had foamy and vacuolated centrilobular hepatocytes (Figure 




Figure 11. Light micrograph of hepatic tissue from voles pretreated 
with 50 mg/kg PB. 
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Figure .12. Light micrograph of hepatic tissue from voles pretreated 
with 80 mg/kg PG. 
Figure 13. Light micrograph of hepatic tissue from voles pretreated 
with 5 mg/kg BNF. 
Figure 14 Light micrograph of hepatic tissue from voles pretreated 
with 80 mg/kg BNF. 
56 
57 
and increased in the 80 mg/kg animals (Figure 14). One tissue sample 
from the 80 mg BNF had large hypertrophied cells similar to 80 PB, but 
other samples resembled the 50 mg/kg PB group. 
Gross examination of PCB treated voles showed greasy livers in 
the PCB 5 groups whereas 40 and 80 mg/kg PCB produced livers that were 
less greasy. At the higher doses, an increase in fibrinous attachments 
to gut viscera occurred. At the 5 mg/kg dose, the hepatocytes 
appeared extremely foamy and vacuolated throughout the lobule with the 
greatest changes in centrilobular region (Figure 15). Livers from the 
group PCB 40, showed slightly foamy cells in the centrilobular region 
and the rest of the tissue had swollen, hypertrophied hepatocytes. 
The 80 mg/kg dose of PCB, showed a reduction in cells that were vacuo-
lated and an increase in swollen hepatocytes (Figure 16), but not to the 
same degree seen in PB 80. 
Gross examination of livers from carbon tetrachloride pretreated 
animals, revealed dry, ischemic livers with petechiation of the surface. 
Histologically, the tissue showed acute hepatic necrosis in the centri-
lobular and midzonal regions with no recognizable cell membrane or 
nuclei in this area. In the periportal regions, hepatocytes showed 
severe fatty degeneration with extreme vacuolation (Figures 17 and 18). 
Figure 15. Light micrograph of hepatic tissue from voles pretreated 
with 5 mg/kg PCB. 
Figure 16, Light micrograph of hepatic tissue from voles pretreated 
with 80 mg/kg PCB. 
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Figure 17. Light micrograph of hepatic tissue from voles pretreated 
with 0.1 ml/kg carbon tetrachloride. 
Figure 18. Light micrograph of hepatic tissue from voles pretreated 




This section is divided into two main areas to better interpret 
the results. The first section involves a discussion of the metabolic 
changes occuring in the liver, due to various doses of PB, BNF and PCB. 
The second topic discusses the morphological changes in hepatic tissue 
and serum enzyme levels, resulting from a low, medium or high dose of 
the inducers. 
In analyzing the results of this study, it is important to consi-
der the complexities involved in the mechanisms that produce the ob-
served effects. First, there are many forms of cytochrome P-450 in-
volved in the hepatic monooxygenase system. Nebert (1979) states there 
may be hundreds of inducible forms of P-450 in mammalian tissues and 
these different enzyme forms may have high specificity for one inducing 
substrate with some degree of cross-specificity for various other sub-
strates. Secondly, the inductive response in enzyme systems is not well 
documented but hypothetical schemes by Conney (1967), Nebert (1979), and 
Rees (1979) all refer to a receptor system which in turn regulates gene 
functions controlling protein synethesis. As a result, genetic varia-
tions between species can effect enzymatic responses produced by xeno-
biotics (Nebert et al. 1977). 
Effects of Inducers PB, BNF and PCB on 
Hepatic Monooxygenase Activity 
Table 2 presents the enzyme activity of aniline hydroxylase (AH), 
t-nitroanisole-Q_-demethylase (PNA) and cytochrome C reductase (CCR) 
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after pretreatment of various doses of either PB, BNF, or PCB. The en-
zyme activity within some of the pretreatment groups have a high stand-
ard deviation. This can be explained by the strain of animals used. 
Most studies utilize inbred strains of laboratory animals to reduce 
the genetic variability. The strain of voles used in this study are 
continually outbred to retain the "wild" genetic parameters, allowing 
for an increase in genetic variability. Nebert et al. (1977) explains 
that monooxygenase activity fluctuates due to genetic predisposition of 
each individual. This indicates outbred voles may then have a high var-
iability in their genetic regulation of enzymatic induction. 
The results shown in Figures 4-9 clearly illustrate that PB, BNF, 
and PCB have varying effects on hepatic monooxygenases. Examining the 
effects produced by the high dose of the inducers, allows comparisons 
to other studies. Keep in mind that 80 mg/kg pretreatment in this study 
implies daily injections of 80 mg/kg for three days making the total 
dose 240 mg/kg over a three day period. Pretreatment with 80 mg/kg PB 
had a significant inductive action on all three enzyme activities. The 
percent induction was 282%, 174%, and 73% for AH, PNA and CCR respec-
tively, with PNA and CCR having higher activities at 100 mg/kg PB (Table 
6 and Figures 7-9). BNF pretreatment of 80 mg/kg produced a signifi-
cant increase only in PNA and CCR activity (Tables 4 and 5), but not 
as high as PB (Figures 5 and 6). PCB at the high dose of 80 mg/kg pro-
duced no significant increase in any of the three enzyme activities in-
vestigated. These results are somewhat different than those reported 
for other animal species. 
The induction potential of polyaromatic hydrocarbon compounds (ie. 
BNF and 3-MC) on vole hepatic mixed function oxidases are dif-
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ferent than the rat, mouse or rabbi 4 but similar to the guinea pig as 
illustrated by Miranda and Chhabra (1980). They showed PB to induce the 
activities of ethylmorphine demethylase, AH, 7-ethoxycoumarin deethylase 
and AHH in the rat, mouse, guinea pig and rabbit; which is similar to 
the results of voles. 3-MC enhanced the deethylase, AH, and AHH 
activities in mice and rats, but only the AH and AHH activities in 
guinea pigs. All enzyme activities were inhibited by 3-MC pretreatment 
in rabbits. Comparison can be made between BNF induction studies and 
3-MC because the effects are similar with 3-MC having a slightly great-
er potentiation of MFO system (Boobis et al., 7977; Wang, 7987 ). 
Other studies have shown species differences in vole MFO activity. 
Hartgrove et al. (1977) showed a marked species difference in microsomal 
MFO activity between pine voles and white mice, pretreating with endrin. 
Makary and Brindley (1983) showed similar results in the mountain vole 
using the substrate bi phenyl. PB induction in voles was higher than 
3-MC or BNF pretreated groups. Also, the ratio of hydroxylated meta-
bolites (2, 3 or 4 hydroxybiphenyl) were different in voles compared to 
mice. 
Aroclor 1254 is a commercial mixture of PCB congeners and induces 
a mixed pattern of microsomal MFO activity in mice and rats, resembling 
the combined effect of 3-MC and PB (Poland and Glover, 7977; Ryan et 
al .,1977). Alvares and Kappas (1977) showed Aroclor 1254 to produce 
similar induction as PB for aniline hydroxylase in rats. Madhukar and 
Matsumura (1981) investigated the effects of several inducers including 
PB, 3-MC and PCB on rat hepatic MFO activity. The activity of cyto-
chrome C reductase was highest with PB pretreatment with slight induc-
tion using 3-MC and PCB; but PNA activity showed the highest induction 
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due to PCB pretreatment. The effect of Aroclor 1254 at 80 mg/kg (simi-
lar doses were used in the studies above), on vole hepatic monooxygenase 
system was minimal (Figures 3-5). This indicated the induction system 
for PCB may not be present in the mountain voles. 
The most interesting aspect of the results shown in Table 2, is the 
effect of different pretreatment levels of the inducers on the micro-
somal enzyme activity. PB, at various levels of pretreatment, produced 
a biphasic response in aniline hydroxylase (AH) as shown in Figures 3 
and 6. Pretreatment with 20 and 40 mg PB produced a significant in-
crease in AH activity over controls but therewas no difference between 
the two dose levels. The next dose level of 80 mg PBwas significantly 
higher than the lower pretreatments (Table 3). The biphasic response of 
PB, may be a result of inducing two different forms of aniline hydroxy-
lase. McCoy (1980) identified two forms of aniline hydro xylase in ham-
sters as having high affinity (low Km; form I) and low affinity (high 
Km; form II). McCoy (1980) determined PB pretreatment of four ip in-
jections of 80 mg/kg induced both forms of AH. He also recalculated 
data from another study, showing similar results in mice and rats. In 
voles, PB doses of 20 and 50 mg/kg may induce only one form of the mi-
crosomal AH, showing a lower induction than 80 mg/kg PB which would in-
duce both forms of AH, producing the maximal AH activity. 
PB produced a significant increase in PNA activity over controls 
at 20 mg/kg and each higher dose of PB produced a significantly greater 
increase in activity over the lower doses (Figure 4 and Table 4). 
Boobis et al. (1977) showed a similar response in AHH activity with 
increasing the dose of BNF and 3-MC. Haugen (1981) also showed this 
effect on biphenyl metabolism with increased levels of 3-MC and PB 
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pretreatment. 
Cytochrome C reductase (CCR) activity showed a triphasic response, 
due to varying the dose of PB (Figure 5 and 8). A significant increase 
in CCR occurred at 20 mg/kg PB and 100 mg/kg with a decrease at 50 and 
80 mg/kg (Table 5). This triphasic response is also seen in CCR with 
pretreatment of BNF as shown in Figure 5. Pretreatment with 5, 20 and 
80 mg/kg BNF produced a significant increase in CCR activity over the 
control, with 20 mg/kg BNF producing the highest response (Table 5 and 
Figures 5 and 8). The mechanism causing the triphasic responses in 
CCR for PB and BNF may be similar to the effect of PB on AH; indicat-
ing there are different forms of CCR that are affected differently de-
pending on the dose of PB or BNF. Another explanation may involve the 
mechanism of induction as described by Bresnick (1978) and Nebert 
(1979). The cytosolic receptor that initiates the enzyme induction 
process may occur in different forms. These receptors may have vary-
ing affinities for the inducer, causing a variation in enzyme induction 
depending on the dose of inducer. 
This response of different receptor affinities is associated with 
the effects of hormones on cell function. In some hormonal responses, 
low levels of the hormone will bind to "very high affinity" receptors 
causing activation. Increasing the hormone level causes inhibition ef-
fects due to "high affinity" receptors, whereas the highest hormone 
levels would again cause activation resulting from the "low affinity" 
receptors (Ellis, 1983). This creates a triphasic response of cellu-
lar function similar to the effect seen in CCR activity from PB and 
BNF pretreatment. 
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Pretreatment with BNF produced a significant decrease in PNA at 
5 mg/kg with 20, 40 and 50 mg/kg showing no significant change from 
control (Figure 4 and Table 4). BNF at 80 mg/kg produced a significant 
induction of PNA over the control values. This againwas similar to 
hormonal effects on cellular enzymatic activity. Ellis and McMullen 
-5 (1982) showed B-endorphin, at a concentration of 10 M, produced an 
increase in monoamine oxidase activity in rat pancreas cells. At a 
lower concentration of l □- 8 M, the monoamine oxidase activity was in-
hibited. 
Effects of increased dose of BNF showed a steady increase in AH, 
but the activity was not significantly different from controls (Figure 
3 and Table 3). Various dose levels of PCB had no significant effect 
on AH activity. This indicated, in the vole, the dose levels given of 
BNF and PCB seem to have no significant induction of the hepatic mono-
oxygenase associated with aniline hydroxylase. Villeneuve et al. 
(1971) showed 1.0 and 10 mg/kg Aroclor 1254 had no effect on AH activ-
ity in pregnant rabbit when calculated as activity per mg protein; indi-
cating a similarity between the vole and rabbit. 
PCB pretreatment of 10 mg/kg significantly increased PNA activity 
with 20 and 80 mg/kg producing no change from control and 40 mg/kg de-
pressing PNA activity (Figure 4 and Table 4). Cytochrome C reductase 
activity showed a significant increase at 5 mg/kg PCB with no effect at 
the higher doses. As mentioned earlier, PCB produces an induction 
similar to the combined effect of PB and 3-MC in rats and mice. The 
results obtained from voles must be species specific by showing no in-
duction or even a reduction of MFO activity at higher dose levels of 
PCB. 
Effects of PB, BNF and PCB on Serum Enzyme 
Levels and Hepatic Morphology 
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Altered membrane permeability of hepatic cells can lead to increased 
serum enzyme activity (Plaa, 1980). Serum glutamic-pyruvic transaminase 
(SGPT) is released from the cytoplasm of injured liver cells and appears 
to be a more sensitive index of hepatic injury than other serum assays 
(Balazs et al., 1962; Traiger and Plaa, 1971; Thomson, 1978). Talcott 
and Ketterman (1981) indicated that serum levels of malathion carboxyl-
esterase may vary due to changes in liver endoplasmic reticulum. They 
showed a high correlation between SG0T levels and serum malathion car-
boxylesterase titers. This suggested that serum activity of malathion 
carboxylesterase may increase when liver damage occurs. 
Changes in SGPT units and serum malathion carboxylesterase activ-
ity due to PB, BNF or PCB pretreatment, are shown in Table 7. The three 
inducers, at different doses, caused a decrease in SGPT units compared 
to control values (Table 7). Carbon tetrachloride was used for a posi-
tive control, elevating the SGPT units to a mean value of 1475 compared 
to 60 from the oil-control animals. Normal levels of SGPT units in hu-
mans range from 6 to 36 (Todd- Sanford, 1974), showing a level close to 
0 as being normal. This indicates the decrease in SGPT units observed 
in the inducer pretreated animals, really is not a positive indicator of 
any liver changes. The lower values in the treatment groups illustrate 
the variability that occurs in normal vole SGPT levels; with the upper 
limit being approximately 117 and a lower value near 5. Pessayre et al. 
(1980) showed PB and 3-MC had no effect on the SGPT levels in rats, 
agreeing with the vole results shown in Table 7. 
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The effect of PB, BNF or PCB on serum malathion carboxylesterase 
activity is shown in Table 7 with similar results as indicated by SGPT. 
Carbon tetrachloride, again used as a positive control, produced a 
significant increase in serum malathion carboxylesterase activity com-
pared to the controls and other treatment groups. Two samples of rat 
serum were assayed, to determine how well the assay was running. The 
mean value, 23.9 n mole/mg Protein-min, matched the value obtained by 
Talcott (1979), indicating the assay was working correctly. The results 
of the rats also : ~owed a significant increase in activity compared to 
vo 1 es. 
General effects of inducer pretreatment on vole body weight and 
1 ivers are shown in Table 1. No significant changes in body weight or 
liver weights occurred between the pretreatment groups. There was a 
significant increase in liver weight in relation to body weight with 
50, 80, and 100 mg/kg PB and 80 mg/kg PCB compared to the control values 
(Table 1). Also, 50, 80, and 100 mg/kg PB caused a significant increase 
in microsomal protein per gr.am liver weight. Augenlicht and Argyris 
(1975) found pretreatment with PB or 3-MC resulted in increased liver 
growth in rats. Argyris (1968) showed rats pretreated with 100 mg/kg 
PB for 5 days produced an increase in liver weight and total protein 
which was associated with the increase of aminopyrine demethylase ac-
tivity. This is in agreement with the results obtained on the voles 
shown in Table 1. Argyris and Layman (1969) showed a slight increase 
in total liver weight and protein in 3-MC treated immature rats. 
Conney and Gilman (1963) illustrated only PB and not 3-MC produced an 
increase in microsomal protein per g of liver for mature rats. 
These studies by Argyris and co-workers, indicate monoo xygenase 
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induction is closely associated with increased liver weights and micro-
somal protein content. This association was demonstrated in the vole 
work with the increase induction of monooxygenase enzyme activity shown 
in Table 2 with PB treatment and the effects on liver weight and pro-
tein in Table 1. Pretreatment with BNF or PCB produced little change 
or a decrease in microsomal protein and the same effect was demonstrated 
in the enzyme activity. This again supports the rational that BNF and 
PCB have little inductive effects in the vole on the enzymes studied. 
Both vehicle treatments, saline and oil, produced a significant 
decrease in microsomal protein per gram liver weight. This may be due to 
the increase in saline or oil uptake into hepatocytes causing a slight 
increase in liver weight compared to protein content. The effect may 
not be seen when a compound is present in the saline or oil because 
slight increases in protein content may occur in response of the meta-
bolism of the compound, thus nullifying the change in liver weight. 
Gross pathological examination of livers from PB treated voles, 
showed enlarged livers which correlated well with the results in Table 
1 on liver weights and protein content. Both BNF and PCB were adminis-
tered in oil causing greasy livers and at higher dose levels, fibrin 
tabs were present. 
Histological evaluation revealed similar changes between PB, BNF, 
and PCB treatment groups, but the effect varied between the inducers 
depending on the dose. At the lower dose levels, all three inducers 
produced foamy and vacuolated hepatocytes. This effect was primarily 
centrilobular in 5 mg / kg PB treated animals while 5 mg BNF pretreatment 
caused centrilobular and midzonal vacuolated cells (Figure 13). PCB 
at 5 mg/kg also showed severe vacuolization of centrilobular and mid-
69 
zonal hepatocytes as shown in Figure 15. This variation of localized 
inducer effects within the liver lobule, agrees with the current liter-
ature showing regional organization of different monooxygenase enzymes 
within the liver lobule (James et al., 1981; W.ilson and Hart, 1981 ). 
Baron et al. (1978) used immunohistochemicaltechniques to sho\<1 PB in-
duced cytochrome P-450 to be located primarily in the centrilobular 
regions while 3-MC indu ced cytochromes were located more uniformil y 
throug hout the lobule. Gumbrecht and Franklin (1982) showed the pres-
ence of different cytochrome P-450 subpopulations distributed within the 
liver lobule, with PB preferentially inducing the P-450 species found 
primarily in the centrilobular region. 
High er dose levels of PB (80 mg/kg) showed decreased vacuolization 
with hepatocytes becoming extremely hypertrophied throughout the lobule 
(Figure 12). The high doses of BNF and PCB produced livers with some 
vacuolization still present but some tissues showed hypertrophied cells 
(Figures 14 and 16), but not as severe as 80 mg/kg PB. Wanson et al. 
(1975) showed enlarged hepatocytes with an intense proliferation of 
smooth endoplasmic reticulum (SER) in rats pretreated with PB. Centro-
lobular hepatocytes were affected initially, but with a longer pretreat-
ment schedule the entire lobule became involved. Orrenius et al. 
(1965) and Staubli et al. (1969) performed similar ultrastructural 
studies in rats, also showing the proliferation of smooth ER in PB 
treated animals. 
Fouts and Rogers ( 1965) investigated the effects of PB and 3-MC on 
hepatocyte ultrastructure in rats. PB again produced proliferation in 
smooth ER along with increased enzymatic activity of several substrates. 
Pretreatment with 3-MC produced a slight increase in smooth ER and in-
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duction of only one enzymatic activity. Results from Fouts and Rogers 
agreed with the conclusions of Conney and Gilman (1963) that 3-MC, in 
contrast to PB, only induces a selective number of hepatic microsomal 
enzymes producing minimal changes in smooth ER and microsomal protein. 
The conclusions of Fouts and Rogers (1965) help to explain the re-
sults produced by vole induction of PB, BNF and PCB. Primary inductive 
changes involves vacuolization of hepatocytes and reveals small induc-
tion of hepatic microsomal enzymes. This occurs at low doses of all 
three inducers. High levels of PB pretreatment produces a secondary 
morphological response of large, hypertrophied hepatocytes as seen in 
Figure 12. Along with this change, is a large induction of all three 
hepatic microsomal enzymes. Pretreatment with 80 mg/kg BNF or PCB 
doesn't produce the secondary changes seen with PB. This implies that 
BNF and PCB inductive response is either minimal in the mountain vole 
or that the response is very selective, affecting the activity of a sel-
ect group of enzymes, different than the ones tested in this study. Ad-
ditional studies investigating the vole hepatocyte ultrastructure and 
testing with a wider range of microsomal enzyme assays, may help to 
understand the phenomenon occurring at higher inducer pretreatment lev-
els in the mountain vole. 
The effect of carbon tetrachloride on vole hepatic tissue was in-
vestigated to give a positive control on hepatic necrosis. The results 
are shown in Figures 17 and 18. The acute effects of carbon tetrachlor-
ide on vole hepatic tissue resembles the classical centrilobular and 
midzonal acute necrosis with periportal fatty degeneration, demonstrated 
in other species (Pl aa, 1980 ; James et a l . , 1981 ) . The initial necrosis 
occurred in the centrilobular and periportal regions because of the concen-
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tration of enzymes that metabolize the chlorinated hydrocarbon into the 
toxic free radical. 
CONCLUSION 
The hepatic monooxygenase system plays an important role in both 
the detoxification as well as the activation of many xenobiotics. 
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There are many forms of cytochrome P-450 involved in the hepatic mono-
oxygenase system, allowing for a high degree of versitility in sub-
strates the system can metabolize. One of the interesting characteris-
tics of this system is the ability of certain compounds to induce the 
rate of enzymatic activity. It is important in toxicology to understand 
the interactions and effects of drugs and environmental contanimants on 
the metabolic activity of liver monooxygenases. 
Previous work has shown the mountain vole, Microtus montanus, to 
have different induction capabilities compared to the rat or mouse. 
This indicated a need to further investigate the inductive properties 
of the hepatic monooxygenase system in the vole. 
In this study, the effects of three inducers phenobarbital (PB), 
B-naphthoflavone (BNF), and Aroclor 1254 (PCB), at high doses, showed 
differing responses on vole hepatic microsomal monooxygenases. PB at 
80 mg/kg produced a significant increase in activity of all three en-
zymes tested whereas 80 mg/kg BNF and PCB did not. BNF produced little 
change in aniline hydroxylase (AH) activity and a slight induction of 
~-nitroanisole-0-demethylase (PNA) and cytochrome C reductase (CCR). 
Pretreatment with PCB produced no change in AH, PNA or CCR activity. 
The effects of BNF and PCB on the hepatic monooxygenase activity, was 
in contrast with reports on other species. 
Varying the pretreatment dose produced interesting results on the 
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hepatic enzyme activity. PB showed a biphasic response in AH activity 
with 20 mg/kg dose increasing activity over control values, 50 mg/kg 
produced the same effect as 20 mg, and 80 mg/kg showed an increase over 
the 20, and 50 mg dose. This is attributed to, two different affinity 
types of aniline hydroxylase having different inductive capabilities. 
The effect of PB on PNA showed each increase in PB dose produced a higher 
induction of the enzyme activity. With CCR, the activity increased at 
20 mg/kg, decreased back to control values at 50 mg/kg and increased 
again at 80 and 100 mg/kg resulting in a triphasic response. 
Different levels of BNF pretreatment showed no significant in-
creases over control values in AH activity. The dose of 5 mg/kg BNF re-
duced the activity of PNA, with 20, 40 and 50 mg/kg having no chang~ 
from controls. The level of 80 mg/kg BNF produced a significant in-
crease in PNA activity. The effect of varying the dose of BNF, on PNA 
activity showed a biphasic response. A triphasic response was shown 
for the effect of BNF on CCR with 20 mg/kg BNF producing a large in-
duction, decreasing to normal activity at 40 and 50 mg/kg and again in-
creasing significantly over control at 80 mg/kg. 
The effects of various doses of PCB on AH activity was no differ-
ent than controls. With PNA, the activity increase at the low dose of 
10 mg/kg and reduction occurred at 40 mg/kg. There was no change from 
control values at the other dose levels. The effects of PCB at 5 mg/kg 
increased CCR activity but no differences from control values were 
shovm at higher levels of PCB. 
The results of BNF and PCB would indicate that adverse changes 
may be occurring in the hepatocytes. But the levels of SGPT and serum 
malathion carboxylesterase, which at high levels are indicative of liver 
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damage, remained the same as control levels in all the inducer pretreat-
ment doses. Upon histogical examination, the cellular features were 
similar between the PB, BNF and PCB pretreatment groups, indicating no 
necrosis from any of the inducers. There were two major morphological 
phases that occurred in the hepatocytes. The first phase involved 
vacuolated hepatocytes and was associated with the low dose inducer 
pretreatment groups. These groups either had no induction of the en-
zymes tested or slight increase in activity. 
enlarged, swollen, hypertrophied hepatocytes. 
The second phase showed 
This was typical of the 
higher doses of PB but only present in some tissues from the high doses 
of BNF and PCB. This indicates that the second phase is associated with 
the higher inductive response of monooxygenase activity. 
The results of different enzyme activities, due to various doses 
of inducers, indicates the complexities involved in the induction mech-
anism of hepatic monooxygenases. The biphasic and triphasic responses, 
resembles the effects of different hormone levels, on cellular function 
involving different affinity receptors in the hormonal response. This 
same system of different receptors may be involved in the process of in-
duction in the monooxygenase system. Further studies are needed to 
better understand this mechantsm; in the mean time, to xicological 
studies should be aware of possible induction differences, based on the 
pretreatment dose. 
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